Additionally, effective August 22, 2023, Suketu Upadhyay has been appointed to the newly-created position of Chief Financial Officer and Executive Vice President – Finance, Operations and Supply Chain.
Appointed
James Kehoe
Chief Financial Officer
FIS ·
Fidelity National Information Services, Inc.
Effective
2023-08-21
Filed
August 22, 2023, 7:59 PM ET
Effective as of August 21, 2023, the Board of Directors of Fidelity National Information Services, Inc. (the “Company”) appointed James Kehoe as the Chief Financial Officer of the Company.
On August 21, 2023, the Company entered into an employment agreement with Arik Maimon pursuant to which Mr. Maimon agreed to serve as Executive Chairman and Chief Executive Officer of the Company
Departed
Joseph Hernandez
Chairman, Chief Executive Officer, and Member of the Board of Directors
Joseph Hernandez resigned as Chairman, Chief Executive Officer, and a member of the Board of Directors (the “Board”) of Blue Water Biotech, Inc. (the “Company”).
Role change
(interim)
Jon Garfield
Chief Financial Officer and interim principal executive officer
Effective August 16, 2023, Board has appointed Jon Garfield, the Company’s Chief Financial Officer, to serve as the Company’s interim principal executive officer during the pendency of Mr. Sapirstein’s appointment.
Effective January 1, 2024, the Company’s Board of Directors (the “Board”) has appointed Mr. Griffiths as President and Chief Executive Officer and as a member of the Board.
On August 21, 2023, the Company also announced that, as part of this leadership transition, Mr. Dufour will depart from his position as President and Chief Executive Officer and as a member of the Board and Bank Board, effective December 31, 2023 (the “Transition Date”).
The Board has appointed Gunnar Kleveland to succeed Mr. Higgins as President and Chief Executive Officer of the Company effective September 1, 2023, and elected Mr. Kleveland to serve as a member of the Board effective that same date.
Role change
(interim)
Yishai Zohar
Interim Principal Financial and Accounting Officer
GELESIS HOLDINGS, INC.
Effective
2023-08-15
Filed
August 21, 2023, 7:59 PM ET
Mr. Yishai Zohar, age 60, the Company’ President and Chief Executive Officer and as a member of the board of directors, was appointed by the Company’ board of directors on August 16, 2023 to succeed Mr. Maltz as the Company’ Chief Compliance Officer, Corporate Secretary, Treasurer, Interim Principal Financial Officer and Principal Accounting Officer, effective as of August 15, 2023.
Departed
Elliot Maltz
Chief Financial Officer
GELESIS HOLDINGS, INC.
Effective
2023-08-15
Successor
Yishai Zohar
Filed
August 21, 2023, 7:59 PM ET
Mr. Elliot Maltz resigned as the Chief Financial Officer, Treasurer, Chief Compliance Officer and Corporate Secretary (and principal financial and accounting officer) of the Company, effective August 15, 2023
Appointed
Simon Harford
Chief Financial Officer
AMICUS THERAPEUTICS, INC.
Effective
2023-08-21
Filed
August 21, 2023, 7:59 PM ET
appointed Simon Harford as the Chief Financial Officer (principal financial officer) of the Company, effective as of August 21, 2023.
Role change
Mark Kent
Chief Executive Officer
Cano Health, Inc.
Effective
2023-08-19
Filed
August 21, 2023, 7:59 PM ET
the Board appointed Mark Kent, currently serving as the Company’s Interim Chief Executive Officer, as its permanent Chief Executive Officer, thereby removing the interim designation.
On August 21, 2023, the Company entered into an employment agreement with Mr. Ying Cao to serve as the chief financial officer of the Company, effective immediately,
On August 20, 2023, J. Scott Hall, President and Chief Executive Officer and a director of Mueller Water Products, Inc. (the “Company”), stepped down from all his positions at the Company effective as of August 21, 2023
Role change
Steven S. Heinrichs
Chief Financial Officer and Chief Legal and Compliance Officer
Steven S. Heinrichs, the current Executive Vice President, Chief Legal and Compliance Officer and Corporate Secretary, was appointed to serve as Chief Financial Officer and Chief Legal and Compliance Officer, effective as of the Transition Date.
On August 14, 2023, the board of directors of BranchOut Food Inc. (the “Company”) appointed Christopher Coulter as the Company’s Chief Financial Officer effective August 14, 2023
The Board of Directors has accepted the Notice as a notice of voluntary resignation by Mrs. Fernandez-McGovern, and not of termination for Good Reason.
Departed
Dan L. Dearen
President and Chief Financial Officer
Axonics, Inc.
Effective
2023-10-02
Successor
Kari Keese
Filed
August 21, 2023, 7:59 PM ET
On August 18, 2023, Dan L. Dearen, President and Chief Financial Officer (Principal Financial and Accounting Officer) of Axonics, Inc. (the “Company”), provided formal notice of his decision to retire from the Company effective October 2, 2023.
Appointed
Kari Keese
Chief Financial Officer
Axonics, Inc.
Effective
2023-10-02
Filed
August 21, 2023, 7:59 PM ET
Effective upon Mr. Dearen’s exit on October 2, 2023, the Company intends to appoint Kari Keese to serve as Chief Financial Officer.
Departed
Rustin Welton
Executive Vice President and Chief Financial Officer
Mr. Alkire will succeed Rustin Welton, who will be transitioning out of his current role of Executive Vice President and Chief Financial Officer effective August 31, 2023, and will serve in an advisory role for a transition period.
Appointed
Joseph A. Alkire
Executive Vice President and Chief Financial Officer
On August 21, 2023, the Board of Directors of Kontoor Brands, Inc. (the “Company”) announced Joseph A. Alkire as Executive Vice President and Chief Financial Officer effective August 31, 2023.
Appointed
Gil Labrucherie
Chief Financial Officer
ACELYRIN, Inc.
Effective
2023-08-17
Filed
August 21, 2023, 7:59 PM ET
On August 17, 2023, the Company appointed Mr. Labrucherie as its full time Chief Financial Officer.
On August 17, 2023, Mr. Michael C. Donegan, the Principal Financial and Accounting Officer of the Company, notified the Company of his decision to resign from such positions, effective as of August 17, 2023.
On August 14, 2023, Robert Potashnick notified the Company of his decision to resign as Chief Financial Officer of the Company, effective as of September 13, 2023, to pursue other opportunities.
Appointed
Ray Chen
Chief Executive Officer
FutureTech II Acquisition Corp.
Effective
2023-08-18
Filed
August 18, 2023, 7:59 PM ET
On August 18, 2023, the Company’s board of directors appointed Ray Chen to serve as Chief Executive Officer and Chief Financial Officer of the Company.
Appointed
Ray Chen
Chief Financial Officer
FutureTech II Acquisition Corp.
Effective
2023-08-18
Filed
August 18, 2023, 7:59 PM ET
On August 18, 2023, the Company’s board of directors appointed Ray Chen to serve as Chief Executive Officer and Chief Financial Officer of the Company.
Departed
Yuquan Wang
Chief Executive Officer
FutureTech II Acquisition Corp.
Effective
2023-08-18
Successor
Ray Chen
Filed
August 18, 2023, 7:59 PM ET
On August 18, 2023, Yuquan Wang resigned as Chief Executive Officer of FutureTech II Acquisition Corp.
Departed
Michael Greenall
Chief Financial Officer
FutureTech II Acquisition Corp.
Effective
2023-08-18
Successor
Ray Chen
Filed
August 18, 2023, 7:59 PM ET
On August 18, 2023, Michael Greenall resigned as Chief Financial Officer of the Company and as a member of the Company’s board of directors, effective immediately.
Departed
Jacob Patterson
Chief Financial Officer
POLARITYTE, INC.
Effective
2023-08-18
Filed
August 18, 2023, 7:59 PM ET
On August 18, 2023, Jacob Patterson, Chief Financial Officer of RegenETP, Inc. (formerly known as PolarityTE, Inc.), a Delaware corporation (the “Company”), informed the Company of his decision to resign effective immediately in order to pursue other opportunities.
On August 15, 2023, Scott Burrows notified Arcutis Biotherapeutics, Inc. (the “Company”) of his decision to resign as chief financial officer of the Company, effective as of August 31, 2023.
The Company has commenced a search for a permanent chief financial officer and has appointed John Smither, who previously served as the Company’s chief financial officer from May 2019 until his retirement in March 2021, as interim chief financial officer, effective upon Mr. Burrows’ departure from the Company on August 31, 2023.
Departed
Corey Campbell
Chief Financial Officer
Perception Capital Corp. III
Effective
2023-08-11
Successor
John P. Stanfield
Filed
August 18, 2023, 7:59 PM ET
Corey Campbell ceased to serve as the Company’s Chief Financial Officer effective as of Mr. Stanfield’s appointment.
Appointed
John P. Stanfield
Chief Financial Officer
Perception Capital Corp. III
Effective
2023-08-11
Filed
August 18, 2023, 7:59 PM ET
On August 11, 2023, Portage Fintech Acquisition Corporation (the “ Company ”) appointed John P. Stanfield to serve as its Chief Financial Officer, effective immediately.
Departed
Shane Torchiana
Chief Executive Officer
Bird Global, Inc.
Effective
2023-08-09
Filed
August 18, 2023, 7:59 PM ET
the departure of Shane Torchiana from his position as the Chief Executive Officer of the Company, effective as of August 9, 2023
On August 17, 2023, David L. Goodin, President and Chief Executive Officer of MDU Resources Group, Inc. (the “Company”), informed the Board of Directors (the “Board”) of the Company of his intention to retire as President and Chief Executive Officer effective as of end of day January 5, 2024.
On August 17, 2023, the Board appointed Nicole A. Kivisto to succeed Mr. Goodin as President and Chief Executive Officer, effective as of January 6, 2024.
Effective August 16, 2023, Joel S. Hatlen is retiring as the Company’s Vice President, Chief Financial Officer, Chief Operating Officer, Corporate Secretary and Treasurer.
Appointed
Gerald Ng
Vice President, Chief Financial Officer, Corporate Secretary and Treasurer
Effective August 16, 2023, Gerald became the Company’s Vice President, Chief Financial Officer, Corporate Secretary and Treasurer.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.